Stockreport

Annovis Bio Interview to Air on Bloomberg International on the RedChip Money Report

Annovis Bio, Inc.  (ANVS) 
PDF BERWYN, Pa., May 01, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease, Parkinson’ [Read more]